A5011675243- Cardiac pacing and defibrillation studies
- Cardiac Arrhythmias and Treatments
- Cardiac electrophysiology and arrhythmias
- Atrial Fibrillation Management and Outcomes
- Cardiac Imaging and Diagnostics
- Cardiac Structural Anomalies and Repair
- Cardiovascular Function and Risk Factors
- Venous Thromboembolism Diagnosis and Management
- Acute Myocardial Infarction Research
- Advanced MRI Techniques and Applications
- ECG Monitoring and Analysis
- Cardiovascular Syncope and Autonomic Disorders
- Heart Failure Treatment and Management
- Cardiac Health and Mental Health
- Heart Rate Variability and Autonomic Control
- Neurological disorders and treatments
- Mechanical Circulatory Support Devices
- Health Systems, Economic Evaluations, Quality of Life
- Cardiovascular and exercise physiology
- Cardiac Valve Diseases and Treatments
- Cardiovascular and Diving-Related Complications
- Coronary Interventions and Diagnostics
- Advanced Battery Technologies Research
- Acute Ischemic Stroke Management
- Antiplatelet Therapy and Cardiovascular Diseases
Alaska Heart and Vascular Institute
2022-2025
Inova Health System
2023-2024
Saint Luke's Hospital
2023
Duke University
2011-2022
Nova Medical (United States)
2021-2022
Duke Medical Center
2013-2022
Duke University Hospital
2011-2021
Inova Design Solutions (United Kingdom)
2021
Inova Fairfax Hospital
2021
Clinical Research Institute
2005-2020
The objective of the current study is to investigate risk heart failure (HF) after implantation a pacemaker (PM) with right ventricular pacing (RVP) lead in comparison matched cohort without PM and factors associated this risk.All patients known history HF who had implanted an RVP between 2000 2014 (n = 27 704) were identified using Danish nationwide registries. An age- gender-matched control (matched 1:5, n 138 520) was compare risk. Outcome cumulative incidence including fatal within first...
LAA Thrombus Among Anticoagulated AF Patients. Introduction: Catheter‐directed atrial fibrillation (AF) ablation is contraindicated among patients with left appendage (LAA) thrombus. The prevalence of thrombus fully anticoagulated undergoing unknown. Methods and Results: We retrospectively evaluated the 192 consecutive between July 2006 January 2009. Seven (3.6%) had evidence on transesophageal echocardiogram (TEE) despite being warfarin (international normalized ratio [INR] 2–3) for 4 weeks...
In patients with left bundle branch block (LBBB), QRS duration (QRSd) depends on ventricular (LV) dimension. Previously, we demonstrated that normalizing QRSd to LV dimension, adjust for variations in size, improved prediction of hemodynamic response cardiac resynchronization therapy (CRT). addition, sex-specific differences CRT outcome have been attributed normalized QRSd. The present study evaluates the effect normalization dimension survival after implantation.In this 2-center study,...
Several studies that used claims and registry data have reported 40% to 80% of patients eligible for an implantable cardioverter defibrillator (ICD) fail receive one in clinical practice, the rates are especially high among women blacks. The extent documented reasons nonuse ICDs with left ventricular systolic dysfunction unknown.Using hospital data, we identified hospitalized a heart failure diagnosis ejection fraction ≤30% between January 1, 2007, August 30, at tertiary-care center. Using...
BackgroundDiabetes mellitus (DM) is an independent risk factor for atrial fibrillation (AF). Few studies have compared clinical outcomes after catheter ablation between patients with and those without DM.ObjectiveThe purpose of this study was to compare AF in DM.MethodsWe performed a retrospective analysis 351 consecutive who underwent first-time ablation. Clinical included freedom from recurrent arrhythmia, symptom burden (Mayo Symptom Inventory score), cardiovascular all-cause...